FNY Investment Advisers’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-6,000
Closed -$22K 655
2021
Q4
$22K Sell
6,000
-6,500
-52% -$23.8K 0.01% 310
2021
Q3
$64K Buy
+12,500
New +$64K 0.03% 285